ROYAL BANK OF CANADA - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q1 2018$01
-95.8%
0.00%
Q4 2017$0240.0%0.00%
Q3 2017$024
+4.3%
0.00%
Q2 2017$0230.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
NEA Management Company, LLC 1,460,209$3,505,0000.13%
Aveo Capital Partners, LLC 93,667$225,0000.08%
Tekla Capital Management LLC 811,227$1,988,0000.07%
ROYCE & ASSOCIATES LP 179,847$441,0000.00%
FRANKLIN RESOURCES INC 1,216,840$2,981,0000.00%
BANK OF AMERICA CORP /DE/ 576$1,0000.00%
NORTHERN TRUST CORP 11,018$26,0000.00%
DEUTSCHE BANK AG\ 60,308$144,0000.00%
GOLDMAN SACHS GROUP INC 16,181$39,0000.00%
MORGAN STANLEY 243$1,0000.00%
View complete list of ARCA BIOPHARMA INC shareholders